Eric A Collisson

Eric A Collisson

UNVERIFIED PROFILE

Are you Eric A Collisson?   Register this Author

Register author
Eric A Collisson

Eric A Collisson

Publications by authors named "Eric A Collisson"

Are you Eric A Collisson?   Register this Author

63Publications

1820Reads

48Profile Views

Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer.

Nat Commun 2019 Jul 11;10(1):3055. Epub 2019 Jul 11.

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, 94158, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-11044-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624260PMC
July 2019

Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.

Fam Cancer 2019 04;18(2):241-251

Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA, 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-018-0106-2DOI Listing
April 2019

Molecular subtypes of pancreatic cancer.

Nat Rev Gastroenterol Hepatol 2019 04;16(4):207-220

Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, Scotland, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41575-019-0109-yDOI Listing
April 2019

Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI.

AJR Am J Roentgenol 2018 11 31;211(5):1010-1019. Epub 2018 Jul 31.

2 Department of Medicine, University of California San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.18.19602DOI Listing
November 2018

Bringing Pancreas Cancer into the Lab.

Authors:
Eric A Collisson

Cancer Discov 2018 09;8(9):1062-1063

Hematology Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://cancerdiscovery.aacrjournals.org/lookup/doi/10.1158/2
Publisher Site
http://dx.doi.org/10.1158/2159-8290.CD-18-0811DOI Listing
September 2018

Advances in the Genetics and Biology of Pancreatic Cancer.

Cancer J 2017 Nov/Dec;23(6):315-320

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000286DOI Listing
July 2018

Exon 14 Mutation Encodes an Actionable Therapeutic Target in Lung Adenocarcinoma.

Cancer Res 2017 08 18;77(16):4498-4505. Epub 2017 May 18.

Division of Hematology and Oncology, Department of Medicine and Helen Diller Family Comprehensive Cancer Center University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-16-1944DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004099PMC
August 2017

Pancreatic Cancer: Progress and Challenges in a Rapidly Moving Field.

Cancer Res 2017 03 16;77(5):1060-1062. Epub 2017 Feb 16.

Department of Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-16-2452DOI Listing
March 2017

Pancreatic Cancer Genomics 2.0: Profiling Metastases.

Cancer Cell 2017 03;31(3):309-310

Departments of Pathology and Translational Molecular Pathology, Sheikh Ahmed Pancreatic Cancer Research Center, UT MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2017.02.014DOI Listing
March 2017

An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer.

Cancer Lett 2016 09 22;380(1):144-52. Epub 2016 Jun 22.

Department of Urology, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology & Oncology, University of California, San Francisco (UCSF), San Francisco, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2016.06.017DOI Listing
September 2016

Election 2016: Voting on Variants.

Cancer Discov 2016 07;6(7):694-6

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-16-0559DOI Listing
July 2016

Re: "Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course".

J Natl Compr Canc Netw 2016 Mar;14(3):lxvi-lxviii

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0040DOI Listing
March 2016

The Authors Respond.

J Natl Compr Canc Netw 2016 Mar;14(3):lxviii

View Article

Download full-text PDF

Source
March 2016

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.

Cancer Discov 2015 Oct 24;5(10):1040-8. Epub 2015 Jun 24.

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. Department of Medicine, University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-15-0274DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592417PMC
October 2015

RADIA: RNA and DNA integrated analysis for somatic mutation detection.

PLoS One 2014 18;9(11):e111516. Epub 2014 Nov 18.

University of California Santa Cruz Genomics Institute, Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0111516PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236012PMC
July 2015

Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course.

J Natl Compr Canc Netw 2015 Jul;13(7):835-45

From the Departments of Obstetrics, Gynecology, and Reproductive Sciences, Medicine, Bioengineering and Therapeutic Sciences, Radiology and Biomedical Imaging, Pathology, Laboratory Medicine, and Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California; and (Present address) Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. From the Departments of Obstetrics, Gynecology, and Reproductive Sciences, Medicine, Bioengineering and Therapeutic Sciences, Radiology and Biomedical Imaging, Pathology, Laboratory Medicine, and Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California; and (Present address) Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. From the Departments of Obstetrics, Gynecology, and Reproductive Sciences, Medicine, Bioengineering and Therapeutic Sciences, Radiology and Biomedical Imaging, Pathology, Laboratory Medicine, and Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California; and (Present address) Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. From the Departments of Obstetrics, Gynecology, and Reproductive Sciences, Medicine, Bioengineering and Therapeutic Sciences, Radiology and Biomedical Imaging, Pathology, Laboratory Medicine, and Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California; and (Present address) Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0101DOI Listing
July 2015

RB and Prognosis in Resected Lung Adenocarcinoma.

Authors:
Eric A Collisson

Clin Cancer Res 2015 Jun 2;21(11):2418-20. Epub 2015 Feb 2.

Department of Medicine, University of California San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2931DOI Listing
June 2015

Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway.

Proc Natl Acad Sci U S A 2015 Jun 16;112(26):7996-8001. Epub 2015 Jun 16.

Departments of Physics and Molecular and Cellular Physiology, Stanford University, Stanford, CA 94305

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1509123112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491781PMC
June 2015

A robust prognostic signature for hormone-positive node-negative breast cancer.

Genome Med 2013 11;5(10):92. Epub 2013 Oct 11.

Department of Cancer and DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, One Cyclotron Rd, Berkeley 94720, CA, USA ; Department of Biomedical Engineering, Center for Spatial Systems Biomedicine, Knight Cancer Institute, Oregon Health and Science University, 3303 SW Bond Ave, Portland, 97239, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gm496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961800PMC
May 2014

Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer.

Proc Natl Acad Sci U S A 2014 Feb 3;111(7):E748-57. Epub 2014 Feb 3.

Departments of Medicine and Epidemiology and Biostatistics and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1320956111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932924PMC
February 2014

Mutationally activated PIK3CA(H1047R) cooperates with BRAF(V600E) to promote lung cancer progression.

Cancer Res 2013 Nov 9;73(21):6448-61. Epub 2013 Sep 9.

Authors' Affiliations: Helen Diller Family Comprehensive Cancer Center; Departments of Cell and Molecular Pharmacology, Hematology and Oncology, and Pathology, University of California, San Francisco, San Francisco, California; and Surgical Oncology Research Laboratory, Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-0681DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825323PMC
November 2013

Single-molecule superresolution imaging allows quantitative analysis of RAF multimer formation and signaling.

Proc Natl Acad Sci U S A 2013 Nov 24;110(46):18519-24. Epub 2013 Oct 24.

California Institute for Quantitative Biosciences, University of California, Berkeley, CA 94720.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1318188110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831949PMC
November 2013

Subtype-specific MEK-PI3 kinase feedback as a therapeutic target in pancreatic adenocarcinoma.

Mol Cancer Ther 2013 Oct 5;12(10):2213-25. Epub 2013 Aug 5.

Corresponding Author: W. Michael Korn, UCSF Divisions of Gastroenterology and Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, 2340 Sutter St., Box 1387, San Francisco, CA 94115.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800201PMC
October 2013

The Cancer Genome Atlas Pan-Cancer analysis project.

Nat Genet 2013 Oct;45(10):1113-20

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2764DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919969PMC
October 2013

What are we learning from the cancer genome?

Nat Rev Clin Oncol 2012 Nov 11;9(11):621-30. Epub 2012 Sep 11.

Department of Medicine/Hematology and Oncology, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2012.159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169265PMC
November 2012

Histology, anatomy, or geography? Exome sequencing begins to delineate somatic mutational differences in esophageal cancer.

Cancer Discov 2012 Oct;2(10):870-1

Department of Medicine, Division of Hematology and Oncology, University of California at San Francisco, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-12-0393DOI Listing
October 2012

PARADIGM-SHIFT predicts the function of mutations in multiple cancers using pathway impact analysis.

Bioinformatics 2012 Sep;28(18):i640-i646

Department of Biomolecular Engineering and CBSE, University of California Santa Cruz, Santa Cruz, CA 95064, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/bts402DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436829PMC
September 2012

Active surrender.

Authors:
Eric A Collisson

Pigment Cell Melanoma Res 2012 May;25(3):292-3

View Article

Download full-text PDF

Source
May 2012

An uphill battle downstream of RAF.

Authors:
Eric A Collisson

J Clin Oncol 2011 Jun 25;29(17):2298-300. Epub 2011 Apr 25.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.34.9316DOI Listing
June 2011

Bioluminescent imaging of melanoma in live mice.

J Invest Dermatol 2005 Jul;125(1):159-165

Department of Microbiology, Immunology, and Molecular Genetics, Harbor-UCLA Medical Center, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.0022-202X.2005.23759.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141554PMC
July 2005

Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells.

Mol Cancer Ther 2003 Oct;2(10):941-8

Department of Medicine, Division of Dermatology, Harbor-UCLA (University of California-Los Angeles), Torrance, CA 90509, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161126PMC
October 2003

Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade.

Cancer Res 2003 Sep;63(18):5669-73

Department of Medicine, Harbor-UCLA Medical Center/UCLA School of Medicine, Torrance, California 90502, USA.

View Article

Download full-text PDF

Source
September 2003

Isoprenylation is necessary for the full invasive potential of RhoA overexpression in human melanoma cells.

J Invest Dermatol 2002 Nov;119(5):1172-6

Department of Medicine, Division of Dermatology, UCLA School of Medicine, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0022202X1530053
Publisher Site
http://dx.doi.org/10.1046/j.1523-1747.2002.19519.xDOI Listing
November 2002

Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome.

Liver Transpl 2002 Oct;8(10):925-31

David Geffen School of Medicine, University of California at Los Angeles School of Medicine, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/jlts.2002.35544DOI Listing
October 2002